Summary Mannose in animal cells is phosphorylated by hexokinase (HK) and later isomerised by mannose phosphate isomerase (MPI) to fructose-6-P, which is incorporated in the glycolysis pathway. In this paper we report a significant decrease of MPI activity in splenic lymphoid cells from AKR/J old mice with lymphocytic leukaemia in comparison to that found in splenic lymphocytes from AKR/J non-leukaemic young mice and BALB/c young and old control mice. However, HK with mannose as substrate presents a normal activity in AKR/J leukaemic mice. This marked shortage of MPI explains the in vitro mannose toxicity found by us here in splenic lymphoid cells from AKR/J leukaemic mice. MPI activity was also decreased in peripheral blood lymphocytes from 4 out of the 6 patients studied with chronic lymphocytic leukaemia in relation to the activity found in the lymphocytes from healthy donors. The utility of analysing MPI activity in leukaemia patients and the use of mannose as an innocuous chemotherapic supporting agent in patients with decreased MPI activity is proposed.
Mannose was known to be toxic for honeybees because of an imbalance between a high hexokinase activity and a low mannose phosphate isomerase activity (Sols et al., 1960; Arnold et al., 1974) . This shortage of mannose phosphate isomerase leads to a large accumulation of mannose-6-phosphate and a marked depletion of ATP when honeybees ingest mannose, being the molecular mechanism proposed for mannose toxicity in these insects (De la Fuente et al., 1986) .
On the other hand, mannose has been found to be teratogenic for rat embryos in vitro (Freinkel et al., 1984) and in vivo (Buchanan et al., 1985) . Mannose has also been reported to be toxic for certain experimental tumours, viz. murine ascites tumour cells (Beseki et al., 1969; Morgan & Eng, 1970) , although not for other murine and human tumour lines (Eagle et al., 1958) .
In this paper we study the activity of the main enzymes involved in mannose and glucose metabolism in splenic lymphoid cells from AKR/J leukaemic mice: (a) hexokinase with mannose as substrate (HK(M)) which transforms it into mannose-6-phosphate; (b) mannose phosphate isomerase (MPI) that then catalyzes the conversion of the abovementioned hexosephosphate to fructose-6-phosphate; (c) hexokinase with glucose as substrate; and (d) glucose phosphate isomerase (GPI). AKR/J mice were used because they spontaneously develop T-cell lymphoma after a latent period of approximately 8 to 12 months (Gross, 1951) , and is an excellent experimental model for the study of this kind of leukaemia. The same enzyme assays were carried out in AKR/J non-leukaemic young mice and in BALB/c mice of a similar age to the two groups of AKR/J mice. Old and young BALB/c mice were used as controls. Moreover, we investigated the in vitro toxic effect of mannose in splenic lymphocytic cells from AKR/J leukaemic mice.
This study of enzymes of mannose and glucose metabolism was also performed in lymphocytic cells of peripheral blood from 6 patients diagnosed with chronic lymphocytic leukaemia. Their activities were compared with those found in lymphocytes from healthy donors.
Materials and methods

Animals
Male and female AKR/J and BALB/c mice were provided by PANLAB and maintained in our laboratory by brother- Collection of splenic lymphoid cells from mice The animals were sacrificed by cervical dislocation, their abdomens opened and the spleens removed aseptically and weighed. In parallel touch preparations were performed to establish a cytological diagnosis of lymphoma. Then the spleens were teased with needles and gently pushed through a mesh screen to obtain a single cell suspension. The mononuclear cells from this splenic suspension were obtained by centrifugation on a gradient of Urograph-Ficoll with a density of 1.076 (Solana et al., 1982) . The halos were resuspended in PBS solution and the washed pellets were weighed and homogenized as described below.
Collection of human lymphocytes from peripheral blood Normal human lymphocytes were obtained by density gradient centrifugation (Boyiim, 1968) from ;0 ml of heparinized blood collected from 3 groups of 5 healthy volunteers each time. The washed pellets were weighed and homogenized as described above for the murine splenic lymphoid cells. Blood from leukaemic patients with high counts (not less than 50,000) were provided by Dr A. Torres of the Reina Sofia Hospital in C6rdoba (Spain) . The lymphoid cells were obtained from this source as indicated above.
Enzyme assays
The splenic suspension and the peripheral blood lymphoid cell suspensions were homogenized with 3 times their weight of 0.1 M HEPES, 0.1 M KCl, 1 mM MgCl2, 2 mM mercaptoethanol, pH 7.4, in a Polytrom homogenizer (at setting 7) over 1 min in 10 sec periods. The homogenization was carried out in an ice bath and 1% Triton X100 was added to the homogenates before the assays.
Hexokinase activity was assayed spectrophotometrically following conventional modified methods (Bergmeyer et al., 1974) at room temperature with 0.5mM mannose or 0.5mM glucose as substrates and 2mM MgATP in a buffer-mixture of 50mM HEPES, 0.1 mM KCI, 10mM MgCl2, pH 7.4, with 0.5 U glucose-6-phosphate dehydrogenase and 0.5 mM NADP+, and, in the case of mannose as substrate, 0.5 U each of mannose phosphate isomerase and glucose phosphate isomerase, following the reaction at 340 nm.
The hexosephosphate isomerases were similarly assayed (Bergmeyer et al., 1974) in the above buffer-mixture with 10mM mannose-6-phosphate plus 0.5U glucose phosphate isomerase for the assay of mannose phosphate isomerase and 0.5mM frustose-6-phosphate for the assay of glucose phosphate isomerase.
In all enzymes 10lp of homogenization mixture were used except glucosephosphate isomerase in which 5 1l were used. animal groups. MPI activity is higher in the young AKR/J and BALB/c mice with values of 1.5 +0.5 Ug-1 and 1.2 + 0.4 U g-1 respectively. This activity in old BALB/c control mice is lower (0.8 + 0.1 U g -1) than in young mice but is still significantly greater than the hexokinase activity. It is this greater activity of MPI with respect to HK(M) in both groups of young animals and in the old BALB/c control mice which produced a HK(M)/MPI ratio lower than 1 (0.4 or 0.6) in these 3 animal groups. However, MPI activity is so low in leukaemic AKR/J mice (0.10+0.04Ug-1) that the ratio HK(M)/MPI is as high as 5.3. Under similar conditions of assay the phosphorylation of glucose (HK(G) activity) by the homogenates of all kinds of lymphoid cells was -3 times faster than that of mannose, which is consistent with typical hexokinases, as previously shown for other specimens (Arnold et al., 1974; De la Fuente et al., 1986) . Glucose phosphate isomerase (GPI) activity was 7 to 10 times that of HK(G) in all groups of mice.
The reduced activity of MPI in relation to that of HK(M) and the consequent HK(M)/MPI ratio higher than 1, found here for the splenic lymphoid cells from old leukaemic AKR/ J mice, had also been shown in honeybees (De la Fuente et al., 1986) . This fact does not occur in other insects studied and in this way mannose ingestion is only toxic in honeybees (Sols et al., 1960; Arnold et al., 1974; De la Fuente et al., 1986) . In the light of these results we studied the possible toxicity of mannose in splenic lymphoid cells from leukaemic, non-leukaemic and control mice.
Mortality of murine splenic lymphoid cells
The results in Figure 2 show the specificity of mannose toxicity for the splenic lymphoid cells from AKR/J leukaemic mice as illustrated by the contrast between the rapid mortality of these cells and the lack of toxicity in the other splenic lymphoid cells from BALB/c old control mice. In these BALB/c mice the mortality is similar to that found with glucose, the sugar used as a viability control. However, for the cells from both groups of animals the readily phosphorylable but not further metabolizable 2-deoxyglucose (Heredia et al., 1964) is toxic. This sugar logically produced the highest mortality. The mortality found for both groups of young AKR/J and BALB/c mice was similar to that indicated for BALB/c old control mice (not shown in Figure 2 ).
From these results it can be deduced that, similarly to honeybees, the toxic effect of mannose in a biological specimen is related to the constitutional scarcity of MPI activity in the presence of a high level of HK(M) and therefore leading to a HK(M)/MPI ratio greater than 1. It is possible that this enzyme activity relation produces an accumulation of high levels of mannose-6-phosphate and a concomitant large decrease in ATP. Other results with Ehrlich ascites tumour cells (Hernandez & De la Fuente, unpublished data) suggest that this mechanism is involved in mannose toxicity for certain tumours. In fact, this is the mechanism of mannose toxicity found in honeybees (De la Fuente et al., 1986) . Indeed, the fact that 2-deoxyglucose was toxic for non-tumour cells, just as mannose is also toxic for the tumour splenic lymphoid cells supports the conclusion that the mechanism of mannose toxicity in these tumour cells involves a large accumulation of a hexosephosphate. patients with chronic lymphocytic leukaemia are shown in Table I . The results of these enzyme activities in the lymphocytes from 3 pools of peripheral blood from 5 donors for each pool are also shown in Table I as controls. MPI activity is lower than HK(M) in 4 of 6 patients studied with a HK(M)/MPI ratio higher than 1 (2.5, 2, 1.5 and 1.2 in each of the 4 patients indicated above). The ratios in the other two patients are similar to those in the controls (0.50+0.01). Similar activities are found in the patients and controls for HK(G) and GPI.
This marked shortage of MPI in 4 of 6 patients studied with chronic lymphocytic leukaemia, also found in splenic lymphoid cells from AKR/J leukaemic mice, could be a metabolic characteristic of several kinds of tumour cells, similar to that found in honeybees. If mannose is a selective toxic agent in those insects this sugar could also have the same effect in some ttmour cells. So, given the harmlessness of mannose in healthy cells, this sugar seems to be a promising and supporting chemotherapic agent in patients whose tumour cells show a decreased MPI activity. However, further in vitro and in vivo studies on the effect of mannose in different tumour cells are necessary before suggesting the widespread use of mannose as a possible anti-tumour agent.
